Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 Visualizações
• 07/13/23
0
0
Embutir
administrator
Assinantes
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários